Stockchase Opinions

Bruce Campbell (2) Medipharm Labs Corp LABS-T COMMENT Apr 27, 2020

It is pure extraction. There are probably 3 or 4 of them. They are a leader. There are not too many companies here that are profitable and these guys are one of them. They do toll extracting for clients as well as getting their own Cannabis and extracting from them. They make a great margin.
N/A

Stock price when the opinion was issued

agriculture
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

BUY
It has gone ka-boom lately. It is a real company. It has revenues. It has contracts outside of the company. It will be a white label supplier of oil. It could go higher.
BUY
Corrected nicely. Extractors are holding better than the producers. If you're starting a position, this is one to look at. Much more upside than the growers. Target is $7.25.
HOLD

An extractor of oils from cannabis. They have the ability to move beyond CBD and THC extraction, into more of a pharmaceutical oil. They have long term contracts. There is some concern they are charging high premiums for extraction, so their margins may shrink in the future. This is not likely to harm them for the next five year, he thinks. A good cash flow producing stock in this space.

RISKY
He has as $6.75 as a speculative buy. He thinks sales continue to track along and thinks this down turn may be the best thing for them. When it comes to CBD oil production everything is being produced in North America. The industry as a whole has been consolidating, but he is still going to wait before buying in as whole.